The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals after-the-fact rebates for two drugs in ...

The antitrust regulator said Wednesday it has imposed fines worth 300 million won (US$213,000) on Jeil Pharmaceutical Co., a ...

Johnson & Johnson sued the U.S. Health and Human Services Department on Tuesday, accusing the agency of blocking its plan to ...

Johnson & Johnson is challenging a federal health agency for blocking its plan to discount drugs through a rebate model ...

J&J announced its plan to replace upfront 34B discounts with the rebate plan in August, but HRSA told the company on Sept. 27 that it would initiate proceedings to terminate the drug maker's ...

The lawsuit escalates the pharmaceutical industry’s fight to rein in the federal drug-discount program known as 340B ... and ...

Johnson & Johnson files suit against HHS over 340B program, proposing hospitals pay full price upfront for drugs and receive ...

Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

PhRMA is pushing to get pharmacy benefit manager (PBM) reform over the line in Congress’ lame-duck session, using its first ...

Walgreens Boots Alliance has a storied history in Chicago, starting with a single retail outlet in 1901, and expanding across ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The AHA Nov. 7 filed a friend-of-the-court brief in the U.S. District Court for the District of Kansas in defense of the ...